Exercise benefits in chronic graft versus host disease: A Murine model study

Medicine and Science in Sports and Exercise

Volumn 45, Issue 9, 2013, Pages 1703-1711

  Fiuza Luces, Carmen ^a,b   Soares Miranda, Luisa ^c   González Murillo, África ^d   Palacio, Jesús Martínez ^e   Colmenero, Isabel ^d   Casco, Fernando ^d   Melén, Gustavo J ^d   Delmiro, Aitor ^f,g   Morán, María ^f,g   Ramírez, Manuel ^d   Lucia, Alejandro ^a  

^a UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^b Research Institute i+12   (Spain)

^c UNIVERSITY OF PORTO   (Portugal)

^d HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^e CIEMAT   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Exercise Is Medicine; Hematopoietic Stem Cell Transplantation; Immune Reconstitution; Inflammation

Indexed keywords

BIOLOGICAL MARKER; CD45 ANTIGEN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADAPTATION; ANIMAL; ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CD4 LYMPHOCYTE COUNT; CHEMISTRY; CHRONIC DISEASE; DISEASE MODEL; FEMALE; FITNESS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; KAPLAN MEIER METHOD; LYMPHOCYTE; MOUSE; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SKELETAL MUSCLE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIGENS, CD45; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; CYCLOSPORINE; DISEASE MODELS, ANIMAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-4; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL FITNESS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883262495     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e31828fa004     Document Type: Article

References (41)

1. Allen RD, Staley TA, Sidman CL. Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur J Immunol. 1993;23(2):333-7
2. Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplant. 1990;5(2):69-82
3. Ayala JE, Bracy DP, James FD, Julien BM, Wasserman DH, Drucker DJ. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action. Endocrinology. 2009;150(3):1155-64
4. Biring MS, Fournier M, Ross DJ, Lewis MI. Cellular adaptations of skeletal muscles to cyclosporine. J Appl Physiol. 1998;84(6):1967-75
5. Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012;12(6):443-58
6. Brandt C, Pedersen BK. The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases. J Biomed Biotechnol. 2010;2010:520258
7. Cheng J, Zhou Y, Chen B, et al. Prevention of acute graft-versushost disease by magnetic nanoparticles of Fe(3)O(4) combined with cyclosporin A in murine models. Int J Nanomedicine. 2011; 6:2183-9
8. Chiodi S, Spinelli S, Ravera G, et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol. 2000; 110(3):614-9
9. Choudhury A, Cohen PL, Eisenberg RA. B cells require ''urturing'' by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus. Clin Immunol. 2010;136(1):105-15
10. Corre E, Carmagnat M, Busson M, et al. Long-Term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections. Haematologica. 2010;95(6):1025-9
11. Deeg HJ, Leisenring W, Storb R, et al. Long-Term outcome after marrow transplantation for severe aplastic anemia. Blood. 1998; 91(10):3637-45
12. Evangelista FS, Krieger JE. Small gene effect and exercise traininginduced cardiac hypertrophy in mice: An Ace gene dosage study. Physiol Genomics. 2006;27(3):231-6
13. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674):1550-61
14. Fiuza-Luces C, Gonzalez-Murillo A, Soares-Miranda L, et al. Effects of exercise interventions in graft versus host disease models. Cell Transplant. 2012;[Epub ahead of print]
15. Flowers ME, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am. 1999;13(5):1091-112, viii-ix
16. Fraser CJ, Bhatia S, Ness K, et al. Impact of chronic graft-versushost disease on the health status of hematopoietic cell transplantation survivors: A report from the Bone Marrow Transplant Survivor Study. Blood. 2006;108(8):2867-73
17. Fry TJ, Mackall CL. Immune reconstitution following hematopoietic progenitor cell transplantation: Challenges for the future. Bone Marrow Transplant. 2005;35(1 Suppl):S53-7
18. Garcia-Roves PM, Huss J, Holloszy JO. Role of calcineurin in exercise-induced mitochondrial biogenesis. Am J Physiol Endocrinol Metab. 2006;290(6):E1172-9
19. Geddes M, Storek J. Immune reconstitution following hematopoietic stem-cell transplantation. Best Pract Res Clin Haematol. 2007;20(2):329-48
20. Gratwohl A, Baldomero H, Aljurf M, et al. Hematopoietic stem cell transplantation: A global perspective. JAMA. 2010;303(16):1617-24
21. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1423-34
22. Herzberg PY, Heussner P, Mumm FH, et al. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2010; 16(12):1707-17
23. Hoydal MA, Wisloff U, Kemi OJ, Ellingsen O. Running speed and maximal oxygen uptake in rats and mice: Practical implications for exercise training. Eur J Cardiovasc Prev Rehabil. 2007;14(6):753-60
24. Levine JE. Implications of TNF-Alpha in the pathogenesis and management of GVHD. Int J Hematol. 2011;93(5):571-7
25. Lira FS, Rosa JC, Yamashita AS, Koyama CH, Batista ML Jr, Seelaender M. Endurance training induces depot-specific changes in IL-10/TNF-Alpha ratio in rat adipose tissue. Cytokine. 2009;45(2):80-5
26. Martin PJ, Schoch G, Fisher L, et al. A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood. 1990;76(8):1464-72
27. Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology. 2000;47(2-3):119-25
28. Medja F, Allouche S, Frachon P, et al. Development and implementation of standardized respiratory chain spectrophotometric assays for clinical diagnosis. Mitochondrion. 2009;9(5):331-9
29. Mercier JG, Hokanson JF, Brooks GA. Effects of cyclosporine A on skeletal muscle mitochondrial respiration and endurance time in rats. Am J Respir Crit Care Med. 1995;151(5):1532-6
30. Mitchell SA, Leidy NK, Mooney KH, et al. Determinants of functional performance in long-Term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versushost disease (cGVHD). Bone Marrow Transplant. 2010;45 (4):762-9
31. Nakamura K, Amakawa R, Takebayashi M, et al. IL-4-producing CD8(+) T cells may be an immunological hallmark of chronic GVHD. Bone Marrow Transplant. 2005;36(7):639-47
32. Neipp M, Exner BG, Ildstad ST. A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance. Transplantation. 1998;66(8):969-75
33. Nicastro H, Zanchi NE, da Luz CR, et al. Effects of leucine supplementation and resistance exercise on dexamethasone-induced muscle atrophy and insulin resistance in rats. Nutrition. 2012;28(4): 465-71
34. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005;98(4):1154-62
35. Powers SK, Criswell D, Lawler J, et al. Regional training-induced alterations in diaphragmatic oxidative and antioxidant enzymes. Respir Physiol. 1994;95(2):227-37
36. Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP. Chronic graft-versus-host disease: Clinical manifestation and therapy. Bone Marrow Transplant. 2001;28(2):121-9
37. Reddy P, Negrin R, Hill GR. Mouse models of bone marrow transplantation. Biol Blood Marrow Transplant. 2008;14(1 Suppl 1): 129-35
38. Schroeder MA, DiPersio JF. Mouse models of graft-versus-host disease: Advances and limitations. Dis Model Mech. 2011;4(3): 318-33
39. Trounce IA, Kim YL, Jun AS, Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol. 1996;264:484-509
40. Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med. 2003;54:29-52
41. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M, Bueren JA. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells. 2006;24(11): 2582-91